Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease

Journal of Clinical Neuroscience

Volumn 7, Issue 3, 2000, Pages 195-202

  Collins, S ^a   Boyd, A ^a   Fletcher, A ^a   Gonzales, M F ^b   McLean, C A ^a   Masters, C L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

14 3 3 proteins; Cerebrospinal fluid; Creutzfeldt Jakob Disease; Magnetic resonance imaging; Recent advances

Indexed keywords

CREUTZFELDT JAKOB DISEASE; DISEASE CLASSIFICATION; ELECTROENCEPHALOGRAM; HISTOPATHOLOGY; HUMAN; PRION DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0033932288     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.1999.0191     Document Type: Review

References (110)

1. Prusiner S. Natural and experimental prion diseases of humans and animals. Curr Opin Neurobiol. 2:1992;638-647.
2. Prusiner S., Hsiao K. Human prion diseases. Ann Neurol. 35:1994;385-395.
3. Kretzschmar H. A., Ironside J. W., DeArmond S. J., Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 53:1996;913-920.
4. Almond J., Pattison J. Human BSE. Nature. 389:1997;437-438.
5. Will R. G., Ironside J. W., Zeidler M. A new variant of Creutzfeldt-Jakob disease. Lancet. 347:1996;921-925.
6. Epstein L., Brown P. BSE and a new variant of Creutzfeldt-Jakob disease. Neurology. 48:1997;569-571.
7. Collins S., Masters C. L. Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective. Med J Aust. 164:1996;598-602.
8. Will R. G., Alperovitch A., Poser S. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol. 43:1998;763-767.
9. Windl O., Dempster M., Estibeiro J. P. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposting mutations and allelic variation in the PRNP gene. Hum Genet. 98:1996;259-264.
10. Parchi P., Giese A., Capellari S. Classification of sporadic Creutzffeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 46:1999;224-233.
11. Pan K-M., Baldwin M., Nguyen J. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci. 90:1993;10962-10966.
12. Daude N., Lehmann S., Harris D. Identification of intermediate steps in the formation of a mutant prion protein to a scrapie-like form in cultured cells. J Biol Chem. 272:1997;11604-11612.
13. Büeler H., Aguzzi A., Sailer A. Mice devoid of PrP are resistant to scrapie. Cell. 73:1993;1339-1347.
14. Collinge J., Whittington M. A., Sidle K. C. Prion protein is necessary for normal synaptic function. Nature. 370:1994;295-297.
15. Tobler I., Gaus S. E., Deboer T. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature. 380:1996;639-642.
16. Sakaguchi S., Katamine S., Nishida N. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature. 380:1996;528-531.
17. Brown D., Qin K., HermsJ. The cellular prion protein binds copper in vivo. Nature. 390:1997;684-687.
18. Stöckel J., Safar J., Wallace A. C., Cohen F. E., Prusiner S. B. Prion protein selectively binds copper(II) ions. Biochemistry. 37:1998;7185-7193.
19. Brown D. R., Schmidt B., Kretzschmar H. A. Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem. 70:1998;1686-1693.
20. Brown D. R., Schulz-Schaeffer W., Schmidt B., Kretzschmar H. A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol. 147:1997;104-112.
21. Brown D. R., Besinger A. Prion protein expression and superoxide dismutase activity. Biochem J. 334:1998;423-429.
22. Bains J., Shaw C. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res REv. 25:1997;335-358.
23. Giese A., Brown D. R., Groschup M. H., Feldmann C., Haist I., Ktetzschmar H. A. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8:1998;449-457.
24. Williams A., Lucassen P. J., Ritchie D., Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol. 144:1997;433-438.
25. Dorandeu A., Wingertsmann L., Chrétien F. Neuronal apoptosis in fatal familial insomnia. Brain Pathol. 8:1998;531-537.
26. Brown D. R., Schmidt B., Kretzschmar H. A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 380:1996;345-347.
27. Perovic S., Schröder H. C., Pergande G., Ushijima H., Müller E. G. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126). Exp Neurol. 147:1997;518-524.
28. Collins S., Law M. G., Fletcher A., Boyd A., Kaldor J., Masters C. L. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 353:1999;693-697.
29. Cousens S. N., Vynnycky E., Zeidler M., Will R. G., Smith P. G. Predicting the CJD epidemic in humans. Nature. 385:1997;197-198.
30. sc)-specific epitope defined by a monoclonal antibody. Nature. 390:1997;74-77.
31. Zochodne D. W., Young G. B., McLachlan R. S., Gilbert J. J., Vinters H. V., Kaufmann J. C. E. Creutzfeldt-Jakob disease without periodic sharp wave complexes: a clinical, electroencephalographic, and pathologic study. Neurology. 38:1988;1056-1060.
32. Bortone E., Bettoni L., Giorgi C., Terzano M. G., Trabattoni G. R., Mancia D. Reliability of EEG in the diagnosis of Creutzfeldt-Jakob disease. Electroencephalogr Clin Neurophysiol. 90:1994;323-330.
33. Brown P., Rodgers-Johnson P., Cathala F., Gibbs C., Gajdusek D. C. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann Neurol. 16:1984;295-304.
34. Brown P., Cathala F., Castaigne P., Gajdusek D. C. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol. 20:1986;597-602.
35. Brown P., Gibbs C., Rodgers-Johnson P. Ann Neurol. 35:1994;513-529.
36. Chiofalo N., Fuentes A., Gálvez S. Serial EEG findings in 27 cases of Creutzfeldt-Jakob disease. Arch Neurol. 37:1980;143-145.
37. Burger L. J., Rowan A. J., Goldensohn E. S. Creutzfeldt-Jakob disease: an electroencephalographic study. Arch Neurol. 26:1972;428-433.
38. Masullo C., Pocchiari M., Neri G. A retrospective study of Creutzfeldt-Jakob disease in Italy (1972-1986). Eur J Epidemiol. 4:1988;482-487.
39. Steinhoff B. J., Rächer S., Herrendorf G. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 53:1996;162-166.
40. Medori R., Tritschler H-J., LeBlanc A. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med. 326:1992;444-449.
41. Zeidler M., Stewart G. E., Barraclough C. R. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet. 350:1997;903-907.
42. Pampiglione G. Electroencephalographic studies after cardiorespiratory resuscitation. Proc R Soc Med. 55:1962;653-657.
43. Smith S. J. M., Kocen R. S. A Creutzfeldt-Jakob like syndrome due to lithium toxicity. J Neurol Neurosurg Pssychiatr. 51:1988;120-123.
44. Millar J. H. D., Coey A. The EEG in necrotizing encephalitis. Electroencephalogr Clin Neurophysiol. 11:1959;582-585.
45. Watson C. P. Clinical similarity of Alzheimer and Creutzfeldt-Jakob disease. Ann Neurol. 6:1979;368-369.
46. Gloor P. EEG characteristics in Creutzfeldt-Jakob disease. Ann Neurol. 8:1980;341.
47. Au W. J., Gabor A. J., Vijayan N., Markland O. N. Periodic lateralized epileptiform complexes (PLEDs) in Creutzfeldt-Jakob disease. Neurology. 30:1980;611-617.
48. Zerr I., Bodemer M., Räcker S. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet. 345:1995;1609-1610.
49. Harrington M., Merril C. R., Asher D. M., Gajdusek D. C. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med. 315:1986;279-283.
50. Jimi T., Wakayama Y., Shibuya S. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clinica Chimica Acta. 211:1992;37-46.
51. Beaudry P., Cohen P., Brandel J. P. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord. 1999;10 40-46.
52. Otto M., Stein H., Szudra A. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol. 244:1997;566-570.
53. Otto M., Wiltfang J., Tumani H. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett. 225:1997;210-212.
54. Hsich G., Kenney K., Gibbs, Lee K. H., Harrington M. G. Creutzfeldt-Jakob disease. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 335:1996;924-930.
55. Zerr I., Bodemer M., Weber T. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med. 336:1997.
56. Zerr I., Bodemer M., Gefeller O. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 43:1998;32-40.
57. Manaka H., Kato T., Kurita K. Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease. Neurosci Lett. 139:1992;47-49.
58. Satoh J-I., Kuohara K., Yukitake M., Kuroda Y. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 41:1999;216-225.
59. Burbelo P. D., Hall A. 14-3-3 proteins: hot numbers in signal transduction. Curr Biol. 5:1995;95-96.
60. Aitken A., Collinge D. B., van Heusden B. P. H. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci. 17:1992;498-501.
61. Will R. G., Zeidler M., Brown P., Harrington M., Lee K. H., Kenney K. L. Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease. Lancet. 348:1996;955.
62. Masters C. L., Harris J. O., Gajdusek D. C., Gibbs, Bernoulli C., Asher D. M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 5:1979;177-188.
63. Rosenmann H., Meiner Z., Kahana E. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology. 49:1997;593-595.
64. Otto M., Wiltfang J., Schütz E. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ. 316:1998;577-582.
65. Schmerr M. J., Jenny A. A diagnostic test for scrapie-infected sheep using a capillary electrophoresis immunoassay with fluorescent-labeled peptides. Electrophoresis. 19:1998;409-414.
66. Schmerr M. J., Jenny A. L., Bulgin M. S. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J Chromatogr. 853:1999;207-214.
67. scmolecules with different conformations. Nat Med. 4:1998;1157-1165.
68. Hadlow W. J., Kennedy R. C., Race R. E. Natural infection of Suffolk sheep with scrapie virus. J Infect Dis. 146:1982;657-664.
69. Kuroda Y., Gibbs, Amyx H. L., Gajdusek D. C. Creutzfeldt-Jakob disease in ice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infect Immun. 41:1983;154-161.
70. Collis S. C., Kimberlin R. H. Long-term persistence of scrapie infection in mouse spleens in the absence of clinical disease. FEMS Microbiol Lett. 29:1985;111-114.
71. Schreuder B. E. C., van Keulen L. J. M., Vromans M. E. W., Langeveld J. P. M., Smits M. A. Preclinical test for prion disease. Nature. 381:1996;563.
72. Hill A. F., Zeidler M., Ironside J., Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet. 349:1997;99-100.
73. Hilton D. A., Fathers E., Edwards P., Ironside J., Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet. 352:1998;703-704.
74. Arya S. C. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet. 349:1997;1322-1323.
75. Kawashima T., Furukawa H., Doh-ura K., Iwaki T. Diagnosis of new variant Creutzfeldt-Jakob disease. Lancet. 350:1997;68-69.
76. Hill A. F., Butterworth R. J., Joiner S. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 353:1999;183-189.
77. Zeidler M., Knight R., Stewart G. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified. BMJ. 318:1999;538.
78. Gálvez S., Cartier L. Computed tomography findings in 15 cases of Creutzfeldt-Jakob disease with histological verification. J Neurol Neurosurg Psychiatr. 47:1984;1244-1246.
79. Schlenska G. K., Walter G. F. Serial computed tomography findings in Creutzfeldt-Jakob disease. Neuroradiology. 31:1989;303-306.
80. Finkenstaedt M., Szudra A., Zerr I. MR imaging of Creutzfeldt-Jakob disease. Radiology. 199:1996;793-798.
81. Kovanen J., Erkinjuntti T., Iivanainen M. Cerebral MR and CT imaging in Creutzfeldt-Jakob disease. J Comput Assist Tomogr. 9:1985;125-128.
82. Urbach H., Klisch J., Wolf H. K., Brechtelsbauer D., Gass S., Solymosi L. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology. 40:1998;65-70.
83. Onofrj M., Fulgente T., Gambi D., Macchi G. Early MRI findings in Creutzfeldt-Jakob disease. J Neurol. 240:1993;423-426.
84. Di Rocco A., Molinari S., Stollman A. L., Decker A., Yahr M. D. MRI abnormalities in Creutzfeldt-Jakob disease. Neuroradiology. 35:1993;584-585.
85. Tartaro A., Fulgente T., Pizzi C. D., Bonomo L., Bocola V., Onofrj M. MRI alterations as an early finding in Creutzfeldt-Jakob disease. Eur J Radiol. 17:1993;155-158.
86. Gertz H-J., Henkes H., Cervos-Navarro J. Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings. Neurology. 38:1988;1481-1482.
87. Yoon S. S., Chan S., Chin S., Lee K., Goodman R. R. MRI of Creutzfeldt-Jakob disease: asymmetric high signal intensity of the basal ganglia. Neurology. 45:1995;1932-1933.
88. Falcone S., Quencer R. M., Bowen B., Bruce J. H., Naidich T. P. Creutzfeldt-Jakob disease: focal symmetrical cortical involvement demonstrated by MR imaging. AJNR. 13:1992;403-406.
89. Yamamoto K., Morimatsu M. Increased signal in basal ganglia and white matter on magnetic resonance imaging in Creutzfeldt-Jakob disease. Ann Neurol. 32:1992;114.
90. Tzeng B-C., Chen C-Y., Lee C-C., Chen F-H., Chou T-Y., Zimmerman R. A. Rapid spongiform degeneration of the cerebrum and cerebellum in Creutzfeldt-Jakob encephalitis: serial MR findings. AJNR. 18:1997;583-586.
91. Uchino A., Yoshinaga M., Shiokawa O., Hata H., Ohno M. Serial MR imaging in Creutzfeldt-Jakob disease. Neuroradiology. 33:1991;364-367.
92. Krüger H., Meesmann C., Rohrbach E., Müller J., Mertens H. G. Panencephalopathic type of Creutzfeldt-Jakob disease with primary extensive involvement of white matter. Eur Neurol. 30:1990;115-119.
93. Iwasaki Y., Ikeda K., Tagaya N., Kinoshita M. Magnetic resonance imaging and neuropathological findings in two patients with Creutzfeldt-Jakob disease. J Neurol Sci. 126:1994;228-231.
94. Bahn M. M., Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol. 56:1999;577-583.
95. Demaerel P., Heiner L., Robberecht W., Sciot R., Wilms G. Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology. 52:1999;205-208.
96. Yee A. S., Simon J. H., Anderson C. A., Sze C-I., Filley C. M. Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt-Jakob disease. Neurology. 52:1999;1514-1515.
97. Ho V. B., Fitz C. R., Chuang S. H., Geyer C. A. Bilateral basal ganglia lesions: pediatric differential considerations. RadioGraphics. 13:1993;269-292.
98. Barkovich A. J., Williams V. G., Koch T. K., Berg B. O. Mitochondrail disorders: analysis of their clinical and imaging characteristics. AJNR. 14:1993;1119-1137.
99. Simmons J. T., Pastakia B., Chase T. N., Shults C. W. Magnetic resonance imaging in Huntington's disease. AJNR. 7:1986;25-28.
100. Matochik J. A., Molchan S. E., Zametkin A. J., Warden D. L., Sunderland T., Cohen R. M. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease. Acta Neurol Scand. 91:1995;153-157.
101. Holthoff V. A., Sandmann J., Pawlik G., Schröder R., Heiss W-D. Positron emission tomography in Creutzfeldt-Jakob disease. arch Neurol. 47:1990;1035-1037.
102. Grünwald F., Pohl C., Bender H. 18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease. Ann Nucl Med. 10:1996;131-134.
103. Kao C-H., Wang S-J., Liao S-Q., Yeh S-H. Tc-99 m HMPAO brain SPECT findings in Creutzfeldt-Jakob disease. Clin Nucl Med. 18:1993;234-236.
104. Miller D. A., Vitti R. A., Maslack M. M. The role of 99 m-Tc HMPAO SPECT in the diagnosis of Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol. 19:1998;454-455.
105. Aharon-Peretz J., Peretz A., Hemli J. A., Honigman S., Israel O. SPECT diagnosis of Creutzfeldt-Jakob disease. J Nucl Med. 36:1995;616-617.
106. de Silva R., Patterson J., Hadley D., Russell A., Turner M., Zeidler M. Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease. BMJ. 316:1998;593-594.
107. Cohen D., Krausz Y., Lossos A., Ben-David E., Atlan H. Brain SPECT imaging with Tc-99 m HMPAO in Creutzfeldt-Jakob disease. Clin Nucl Med. 14:1989;808-810.
108. Shih W. J., Markesbery W. R., Clark D. B. Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). J Nucl Med. 28:1987;1484-1487.
109. Markus H. S., Harrison M. J. H., Costa D. C. Single photon emission tomography in growth-hormone related Creutzfeldt-Jakob disease. Lancet. 338:1991;630-631.
110. Watanabe N., Seto H., Shimizu M. Brain SPECT of Creutzfeldt-Jakob disease. Clin Nucl Med. 21:1996;236-241.